TD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BUY now (starter position). TD is in a broader uptrend (bullish moving-average stack), is trading near immediate support (~93.13), and options positioning leans bullish (low put/call ratios). Near-term momentum is soft (bearish MACD), but with no negative news catalyst and a generally improving Wall Street stance (multiple target raises + a recent upgrade), the risk/reward favors buying at current levels for an impatient buyer rather than waiting for a “perfect” setup.
Price/Trend: Despite today’s -1.52% regular-session dip to ~93.49 (post-market), the trend structure remains constructive with SMA_5 > SMA_20 > SMA_200 (bullish stack). Momentum: MACD histogram is negative (-0.309) and expanding lower, signaling weakening short-term momentum; RSI(6)=42.1 is neutral-to-slightly weak (not oversold). Levels: Pivot=94.499 (price is below pivot = short-term bearish bias). Support S1=93.128 (very close—key line to hold), S2=92.281. Resistance R1=95.871 then R2=96.718. Pattern-based odds: Model implies ~70% chance of a small -0.59% next day, but positive skew over 1 week (+1.73%) and 1 month (+2.52%).
Intellectia Proprietary Trading Signals
Prior quarter commentary highlights better-than-expected fee revenue and U.S. Retail strength (supports earnings momentum narrative).
Short-term momentum is weakening: MACD is negative and deteriorating; price is below the pivot (94.499), so a quick rebound is not guaranteed.
No fresh news catalysts in the last week—upside may rely on general market/rates/bank sector tone rather than an immediate event.
Latest quarter showed profit pressure: Net income and EPS declined YoY despite strong revenue growth.
Latest quarter: 2025/Q4. Revenue: 12.658B, +20.50% YoY (strong top-line growth). Net income: 3.089B, -10.26% YoY (profit declined). EPS: 1.82, -7.61% YoY (earnings per share down). Takeaway: Growth is being driven at the revenue line, but profitability/EPS contracted—consistent with a bank facing higher costs/credit normalization, even as business volume/fees improve.
Recent trend: Clear tilt toward higher price targets since early Dec, with one meaningful upgrade. Highlights: National Bank upgraded to Outperform (C$134). BMO/Canaccord raised targets and stayed positive (Outperform/Buy). Several firms remain neutral/hold (UBS Neutral, Jefferies Hold, Raymond James Market Perform, Scotiabank Sector Perform). Barclays remains Underweight despite a target raise. Wall Street pros: improving earnings momentum into 2026 narrative, solid recent execution, and perceived valuation support. Wall Street cons: not unanimous conviction (many Holds/Neutrals) and at least one persistent bear (Underweight), reflecting concerns around profitability/expense/credit-cycle sensitivity.
